0001454189-13-000001.txt : 20130906 0001454189-13-000001.hdr.sgml : 20130906 20130906153231 ACCESSION NUMBER: 0001454189-13-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20130906 DATE AS OF CHANGE: 20130906 EFFECTIVENESS DATE: 20130906 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Auspex Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001454189 IRS NUMBER: 954862842 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-186938 FILM NUMBER: 131082889 BUSINESS ADDRESS: STREET 1: 3366 N. TORREY PINES COURT STREET 2: SUITE 225 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 558-2400 MAIL ADDRESS: STREET 1: 3366 N. TORREY PINES COURT STREET 2: SUITE 225 CITY: LA JOLLA STATE: CA ZIP: 92037 D/A 1 primary_doc.xml X0706 D/A LIVE 0001454189 Auspex Pharmaceuticals, Inc. 3366 N. TORREY PINES COURT SUITE 225 LA JOLLA CA CALIFORNIA 92037 (858) 558-2400 DELAWARE None None Corporation true David Collier c/o CMEA Ventures One Letterman Dr., Bldg. C, Ste. CM500 San Francisco CA CALIFORNIA 94129 Director Sep Sarshar c/o Auspex Pharmaceuticals, Inc. 3366 N. Torrey Pines Ct., Ste. 225 La Jolla CA CALIFORNIA 92037 Director Samuel Saks c/o Auspex Pharmaceuticals, Inc. 3366 N. Torrey Pines Ct., Ste. 225 La Jolla CA CALIFORNIA 92037 Director Andreas Sommer c/o Auspex Pharmaceuticals, Inc. 3366 N. Torrey Pines Ct., Ste. 225 La Jolla CA CALIFORNIA 92037 Executive Officer David. A. Stamler c/o Auspex Pharmaceuticals, Inc. 3366 N. Torrey Pines Ct., Ste. 225 La Jolla CA CALIFORNIA 92037 Executive Officer Pratik Shah c/o Auspex Pharmaceuticals, Inc. 3366 N. Torrey Pines Ct., Ste. 225 La Jolla CA CALIFORNIA 92037 Executive Officer Director Rod Ferguson c/o Auspex Pharmaceuticals, Inc. 3366 N. Torrey Pines Ct., Ste. 225 La Jolla CA CALIFORNIA 92037 Director Pharmaceuticals Decline to Disclose 06 true 0001454189-12-000003 2012-10-31 false true false 0 27992742 27992742 0 false 9 0 0 0 false Auspex Pharmaceuticals, Inc. /s/ Andreas Sommer, PhD Andreas Sommer, PhD President & CEO 2013-09-06